(1 → 3)-β-d-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial

PURPOSE: To investigate whether (1 → 3)-β-d-Glucan (BDG)-guidance shortens time to antifungal therapy and thereby reduces mortality of sepsis patients with high risk of invasive Candida infection (ICI). METHODS: Multicenter, randomized, controlled trial carried out between September 2016 and Septemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloos, Frank, Held, Jürgen, Kluge, Stefan, Simon, Philipp, Kogelmann, Klaus, de Heer, Geraldine, Kuhn, Sven-Olaf, Jarczak, Dominik, Motsch, Johann, Hempel, Gunther, Weiler, Norbert, Weyland, Andreas, Drüner, Matthias, Gründling, Matthias, Meybohm, Patrick, Richter, Daniel, Jaschinski, Ulrich, Moerer, Onnen, Günther, Ulf, Schädler, Dirk, Weiss, Raphael, Putensen, Christian, Castellanos, Ixchel, Kurzai, Oliver, Schlattmann, Peter, Cornely, Oliver A., Bauer, Michael, Thomas-Rüddel, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273538/
https://www.ncbi.nlm.nih.gov/pubmed/35708758
http://dx.doi.org/10.1007/s00134-022-06733-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273538/
https://www.ncbi.nlm.nih.gov/pubmed/35708758
http://dx.doi.org/10.1007/s00134-022-06733-x

Ejemplares similares